2. Search Result
Search Result
Results for "

BMS646256

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-14791
    Ibipinabant
    1 Publications Verification

    SLV319; BMS-646256

    		 Cannabinoid Receptor Metabolic Disease
    Ibipinabant (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM. Ibipinabant shows more than 1000-fold selectivity for CB1 over CB2 (Ki=7943 nM). Ibipinabant can be used for the research of obesity and diabetic .
    Ibipinabant
  • HY-14791A
    (±)-Ibipinabant
    1 Publications Verification

    (±)-SLV319; (±)-BMS-646256

    		 Cannabinoid Receptor Metabolic Disease
    (±)-Ibipinabant ((±)-SLV319) is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM.
    (±)-Ibipinabant